Care planning in idiopathic pulmonary fibrosis
No Ambulance After Half An Hour For B.C. Woman And, She Learned, None Available
Breadcrumb Trail Links
After the 76-year-old was told nothing was available, bystanders flagged down a passing ambulance
Published Sep 09, 2024 • Last updated Sep 10, 2024 • 4 minute read
Join the conversation
You can save this article by registering for free here. Or sign-in if you have an account.
Sandra Earle was crossing the street when she suddenly became overwhelmingly dizzy and short of breath.
Worried she might lose consciousness at any moment, the 76-year-old called 911 for an ambulance.
It was Monday, Aug. 19, just before 1 p.M. And Earle said she was terrified that her symptoms were serious — even life or death.
The "very nice" dispatcher kept her on the line for nine minutes before she had to go, Earle said. She told Earle an ambulance would be on the way, but didn't offer an estimated time of arrival.
Advertisement 2
This advertisement has not loaded yet, but your article continues below.
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
or
Article content
Earle said she lay on the ground so as not to fall, which attracted a crowd of bystanders offering assistance. Earle also called in a friend.
About half an hour later, at 1:28 p.M., with no ambulance in sight, Earle called again. This time, she was told no ambulances were available, and she hung up in frustration.
"He was like sorry, there's no ambulances available and I can't guarantee when one will come and just left me in the call."
As a light rain began to fall, Earle said she felt "absolutely devastated" that no assistance was coming "and I knew something was terribly wrong with me." The dispatcher called back a minute later to suggest she arrange her own transportation to the nearest hospital, Saanich Peninsula Hospital.
She got into the back of her car with the intention of having her friend drive her to the hospital, but said she was near passing out "and it terrified me."
"What if I died and she was driving me?" said Earle. "It would have been traumatic for everyone."
It was at that moment that bystanders saw an ambulance and flagged it down. "It wasn't even for me — it was for someone else."
Sunrise
Thanks for signing up!
Article content
Advertisement 3
This advertisement has not loaded yet, but your article continues below.
Article content
The bystanders asked the paramedics to assess Earle's condition "and they realized the severity of the situation and took me to Saanich Peninsula."
A subsequent CT scan showed what's called a large saddle pulmonary embolism, a rare type of sudden or acute pulmonary embolism that occurs when a large blood clot becomes lodged at the point where the main pulmonary artery divides and branches off into the left and right lungs. That kind of blockage prevents blood flow to both lungs, according to the online publication Medical News Today.
Earle was transferred to Victoria's Royal Jubilee Hospital, where an ultrasound was done on her leg. It turned out the pulmonary embolism was caused by blood clots deep in the veins of her leg — called deep vein thrombosis.
She had "no idea" this deep vein thrombosis was forming — any possible symptoms she had dismissed as resulting from age or inactivity.
"Once I was in the hands of the ambulance and both hospitals, my care was exemplary," said Earle.
"It was wonderful."
Earle is now home in Sidney, receiving ongoing treatment and taking anticoagulants.
Advertisement 4
This advertisement has not loaded yet, but your article continues below.
Article content
She said she has only ever called an ambulance once, last fall, for an unrelated matter, and it arrived in a timely manner. But after last month's experience, she's worried about what will happen if she or any of her loved ones need immediate care.
"What if it was someone older than me and not as lucid — would they just lie there in the grass and who knows?"
She's also wondering why police or firefighters couldn't have been sent to assess the situation if the ambulance service in the area was busy with a higher-priority case. At no time did the dispatcher ask to speak to the bystanders to get greater clarity on the severity of the situation, she said.
Bowen Osoko, spokesperson for B.C. Emergency Health Services, said in a statement on Friday the ambulance service continues to look into the specifics of the case, but said the service prioritizes ambulance calls based on information received from the caller.
"Based on information provided by the patient, the call was coded yellow, or non-urgent," meaning not serious or life-threatening, he said. "The call's colour coding did not change following subsequent communication with the patient."
Advertisement 5
This advertisement has not loaded yet, but your article continues below.
Article content
The highest-priority purple is for life-threatening cases such as cardiac arrest, red is also for life-threatening or critical symptoms such as chest pain, orange is for urgent and potentially serious but not immediately life-threatening cases, while yellow is for non-urgent cases such as a sprained ankle.
Osoko said Earle's call was coded yellow in part because she was speaking coherently and breathing and conscious. Fire-department paramedics typically are sent on an incident coded orange and above, he said.
There is a process to upgrade a call to a higher-priority response "if a patient's condition worsens," he said.
Earle said she has contacted Island Health's patient care quality office, which will review her case.
ceharnett@timescolonist.Com
Recommended from Editorial
A father's anguish captured. And how a baby on a stretcher lived to give back to B.C. Children's Hospital
More B.C. Hospitals embrace trend of sending 'admitted' patients home to heal
Article content
Share this article in your social network
Comments
Join the Conversation
Postmedia is committed to maintaining a lively but civil forum for discussion. Please keep comments relevant and respectful. Comments may take up to an hour to appear on the site. You will receive an email if there is a reply to your comment, an update to a thread you follow or if a user you follow comments. Visit our Community Guidelines for more information.
Spontaneous Coronary Artery Disease In A Healthy Fibromuscular Dysplasia Patient: A Case Report ()
Spontaneous Coronary Artery Disease in a Healthy Fibromuscular Dysplasia Patient: A Case Report ()
1. Introduction
Spontaneous coronary artery dissection is a tear in the intimal layer of epicardial coronary arteries causing an intramural hematoma that can partially or completely occlude the blood flow in the vessels. It is an underrecognized condition that can cause myocardial ischemia or infarction, arrhythmia, or sudden cardiac death. There are multiple risk factors that can precipitate SCAD including hypertension, hyperlipidemia, connective tissue diseases, fibromuscular dysplasia, emotional stress and hypothyroidism. SCAD is diagnosed primarily by cardiac catheterization and coronary angiogram, but intravascular imaging can also be done [1]. FMD is a rare arteriopathy that causes narrowing of blood vessels commonly renal, carotid and vertebral vessels, but can impact any blood vessel in the body [2]. The etiology of FMD is accounted for by an interplay among genetic predisposition, estrogen hormone exposure especially in middle-aged females, and environmental factors [2]. There is an increased prevalence of FMD in patients with SCAD presenting with symptoms of acute coronary syndrome [3]. Research is sparse regarding how ACS manifests in FMD patients and how it can be investigated. ACS itself entails NSTEMI, STEMI, or unstable angina depending on the ECG findings and troponin levels. In this case, the patient elevated enzymes with normal ECG strongly correlated with NSTEMI. While more common causes of NSTEMI exist [4], we take the opportunity here to warn against overlooking SCAD-related NSTEMI especially in patients who denied smoking, alcohol, drug use, and had a generally healthier active lifestyle.
2. Case Presentation
A 72-year-old woman with a history of paroxysmal atrial fibrillation, deep vein thrombosis, pulmonary embolism diagnosed a year prior, fibromuscular dysplasia and hyperlipidemia presented to the Emergency Department by EMS on the night of April 30th of 2024. She reported experiencing chest pain throughout the day, prompting an initial visit to the ED earlier that day. However, her symptoms subsided, and she was discharged home. Later that evening, while standing at her kitchen counter, she lost consciousness and fell backward, striking her head.
Upon arrival at the ED, the patient reported chest pain and the fall. Although the patient had a history of paroxysmal atrial fibrillation, her ECG was normal when she presented. Arrhythmias including atrial fibrillation itself can be due to many underlying causes, one of these causes is SCAD [5]. The medication on file was Eliquis (apixaban) 5 mg twice daily. Vitals signs were stable, and the physical exam confirmed non reproducible chest pain at presentation. Labs showed an initial troponin level of 279 ng/dL, suggestive of potential heart damage. A potassium level of 3.0 mEq/L was noted. A CT scan raised concerns about a possible nondisplaced cervical spine fracture at C2. Repeat troponin levels showed an increase to 364 ng/dL. Due to the elevated troponin levels suggestive of NSTEMI and the potential cervical spine fracture, the decision was made to place the patient in a cervical collar and initiate a Heparin drip. The patient was transferred to a level 1 trauma center for further evaluation and management.
Upon arrival at the trauma center on May 1st, additional CT scans were performed to assess other potential injuries from the fall. The Heparin drip resumed. Consultations were made with cardiology, neurosurgery and trauma surgery for comprehensive evaluation and treatment planning. Repeat troponin levels showed a further increase to 544 ng/dL. The patient was admitted under the care of the trauma team. CT angiography revealed a possible pseudoaneurysm on the left internal carotid artery (Figure 1), prompting consultation with neuroendovascular specialists. Neurosurgeons cleared the cervical spine, allowing for the removal of the cervical collar.
Figure 1. Arrows pointing to the pseudoaneurysmal malformation.
Cardiology evaluated the patient on May 2nd and planned for a left heart catheterization later that day. They also recommended a cath lab and initiating medications including intravenous heparin drip, aspirin, a statin, and a beta-blocker. The patient underwent a left heart cath in the afternoon. The procedure revealed a 100% blockage in the distal-apical left anterior descending artery. This blockage could be due to either embolic phenomena or SCAD. Other coronary arteries showed mild disease, and the left ventricle maintained good systolic function. A transesophageal echocardiogram (TEE) was performed during the cath, which revealed mild to moderate tricuspid regurgitation and a slightly enlarged left atrium. The ejection fraction was 55%. Cardiology recommended continued medical management with Eliquis and lifestyle modifications to control risk factors.
Later that night, the patient developed severe left-sided chest pain radiating to the neck and back improved with sublingual nitroglycerin. An ECG and chest X-ray were normal. Troponin levels continued to rise, reaching 901 ng/dL. Cardiology placed the patient on triple therapy with aspirin, Plavix (generic name Clopidogrel) and Eliquis. Hematology and oncology were consulted to investigate a possible hypercoagulable state. They suggested anticoagulation failure due to the recurrence of presumed thromboembolic phenomenon while on anticoagulant therapy. This also raised the possibility of antiphospholipid syndrome. However, testing for antiphospholipid antibodies came back negative. Hematology and oncology recommended switching the blood thinner to Warfarin.
On May 5th, the patient complained of chest discomfort described as indigestion. The ECG was normal, but troponin levels continued to climb, reaching 1120 ng/dL. Sublingual nitroglycerin was administered again. Morphine and Zofran were given intravenously. A nitroglycerin drip was started, and the patient was transferred to the cardiac ICU due to worrying symptoms and rising troponin levels.
Due to the persistently elevated troponin levels suggestive of a type 1 NSTEMI. Cardiology decided to perform coronary angiography on May 7th to investigate potential distal coronary embolization or thrombotic phenomena. The coronary angiogram confirmed the very distal-apical LAD is very tortuous with 100% occlusion in the apical area and is small in caliber, left to left collaterals seen, possible embolic phenomena vs SCAD, the artery is small around a very tortuous segment and will treat medically. Giving the findings of the angiogram, conservative management was more appropriate in this case, taking into consideration the consequences on any procedural intervention [6]. A TEE with bubble study was performed to assess for a patent foramen ovale. Agitated saline was used to create bubbles and see if they passed through the PFO. The TEE with color flow showed a normal left ventricular function. The interatrial septum had a Grade I positive bubble study where 1 to 9 bubbles were seen passing through the PFO during the test which is considered insignificant, and 100 - 300 bubbles is the most significant or Grade IV.
After the patient stabilized, she was discharged home on Warfarin and Clopidogrel. Eliquis and Aspirin were discontinued at discharge with instructions to follow up with cardiology, neuroendovascular, and hematology/oncology for continued management of the hypercoagulable state.
3. Discussion
FMD is a non-atherosclerotic, non-inflammatory vascular disease that predominantly affects medium-sized arteries, causing arterial stenosis, occlusion, aneurysm, and dissection [7]. It has a strong association with SCAD, particularly in women, and is recognized as a significant underlying condition in many SCAD cases. In this patient, the diagnosis of FMD was reinforced by neuroendovascular findings of multivessel involvement, including a pseudoaneurysm in the left internal carotid artery (ICA), highlighting the systemic nature of the disease.
The exact mechanism linking FMD and SCAD is not very clear, but FMD's inherent structural arterial abnormalities likely predispose to dissection under stress or minor trauma. FMD causes fibroplasia of the media with alternating areas of smooth muscle loss in the vascular walls eventually leading to dilatation and formation of fibromuscular ridges [8]. The alternating areas of dilatation and constriction lead to the beaded appearance of the vessels like the pattern depicted in this patients' imaging in Figure 2 and Figure 3. Those weakened vessel walls are at higher risk of damage by sheer force of blood leading to intimal tear and dissection [9]. The tear can trigger thrombus formation leading to complete or partial blockage of the blood flow. In cases that occur in the coronary arteries, it manifests as one of the diseases under the umbrella of ACS such as NSTEMI in this patient.
The pathophysiology highlighted above provides a reasonable explanation for this case disease progression. The patient's SCAD presented as a 100% occlusion of the distal-apical LAD artery, detected during a coronary angiogram. The absence of significant atherosclerotic disease elsewhere in the coronary circulation supports the SCAD diagnosis over atherosclerotic plaque rupture, which typically underlies the NSTEMI. The patient's recurrent episodes of chest pain and rising troponin levels with normal ECG further corroborate the diagnosis of SCAD-related NSTEMI.
Figure 2. Carotid angiogram with arrows pointing to the FMD showing the beaded appearance of the vessel. There is a fusiform dilatation near the bifurcation representing the pseudoaneurysm.
Figure 3. Similar Finding to Figure 1.
Management of SCAD in the context of FMD is primarily conservative, focusing on symptom relief and prevention of further dissection or embolization compared to interventional approach with cath lab with or without stents if required [10]. In this patient, initial inpatient treatment included Heparin drip and Nitroglycerin followed by antiplatelet therapy (ASA, Plavix) and anticoagulation with Warfarin. We here encourage prophylaxis against thromboembolic events with multiple medications in patients who showed recurrence of symptoms while on one therapy (for example, Eliquis in this case) or switch to more potent alternative treatment options. Given the systemic involvement of FMD and associated complications such as pseudoaneurysms, a multidisciplinary team approach involving cardiology, neurosurgery, trauma surgery, and neuroendovascular specialists is also crucial in long-term management [11].
4. Conclusion
This case report details a complex interplay between FMD, a known predisposing factor, and SCAD, leading to a NSTEMI in a 72-year-old female patient. We highlight the findings suggesting FMD as a plausible underlying cause of SCAD. Patients who have recurrent episodes of NSTEMI without underlying risk factors should investigate the not-so-common causes. To ensure better control of these episodes, a more adamant plan with anticoagulant and antiplatelet should be considered in addition to a rigorous follow-up. Interventional procedures might not be necessary since conservative management proved to be as effective with less adverse events.
Anemia Is A Risk Factor For Peripheral Artery Disease Progression During Hemodialysis
Anemia appears to be an independent risk factor for peripheral arterial disease (PAD) progression among patients undergoing maintenance hemodialysis.
In the Qâ€Cohort study of 3504 Japanese patients on hemodialysis, 257 patients (7.3%) experienced their first major adverse limb event over a median follow-up period of 8 years. Therapeutic interventions for progression of lower extremity PAD included endovascular treatment, bypass surgery, and limb amputation. Patients who experienced other cardiovascular events were more likely to develop PAD during follow-up.
In a multivariable-adjusted Cox proportional hazards model, the risk of major adverse limb events was significantly increased by 70% among patients with a hemoglobin concentration less than 10.0 g/dL compared with 11.0 to 11.9 g/dL, Toshiaki Nakano, MD, PhD, of Kyushu University in Fukuoka, Japan, and colleagues reported in the Journal of the American Heart Association. This was particularly the case for patients who did not receive iron treatments or who had high serum ferritin levels. Patients with hemoglobin values less than 10g/dL had the highest erythropoietin resistance index (ERI), the investigators pointed out.
Hemoglobin levels of 12.0 g/dL or higher were not associated with an increased risk of limb events, except in the subgroup who did not receive iron therapies or erythropoiesis-stimulating agents (ESAs). This finding warrants further investigation, according to Dr Nakano's team.
Iron status, ERI, and the use of ESAs were potential effect modifiers in the association between anemia and the risk for major adverse limb events, according to the investigators. Patients taking renin-angiotensin-system (RAS) inhibitors showed some protection against limb events.
The study lacked data on PAD status at enrollment and some other relevant factors.
"Our results suggest that maintaining blood hemoglobin concentration in an optimal range may reduce the risk of lower extremity PAD progression in hemodialysis populations," Dr Nakano's team wrote. "Further clinical studies are necessary to determine whether correction of anemia by ESAs, iron supplementation, or other treatments, including HIF-PH inhibitors, can slow the progression of lower extremity PAD and reduce the risk of MALE in patients undergoing hemodialysis."
This article originally appeared on Renal and Urology News
References:
Kohara C, Yamada S, Tanaka S, et al. Blood hemoglobin concentrations and the incidence of lower extremity peripheral arterial disease in patients undergoing hemodialysis: 10-year outcomes of the Q-Cohort study. J Am Heart Assoc. Published online August 6, 2024. Doi:10.1161/JAHA.123.033853
Comments
Post a Comment